The Enterprise Value as of December 2025 (TTM) for Concord Drugs Limited (CONCORD.BO) is 751.23M

According to Concord Drugs Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 751.23M. This represents a change of 62.36% compared to the average of 462.71M of the last 4 quarters.

Concord Drugs Limited (CONCORD.BO) Historical Enterprise Value (quarterly & annually)

How has CONCORD.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Concord Drugs Limited over the last ten years is 420.86M. The current 751.23M Enterprise Value has changed 17.75% with respect to the historical average. Over the past ten years (40 quarters), CONCORD.BO's Enterprise Value was at its highest in in the March 2017 quarter at 619.89M. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

Concord Drugs Limited (CONCORD.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Concord Drugs Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Concord Drugs Limited (CONCORD.BO) Average Enterprise Value

How has CONCORD.BO Enterprise Value performed in the past?

The current Enterprise Value of Concord Drugs Limited (CONCORD.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Concord Drugs Limited (CONCORD.BO) Enterprise Value vs. Peers

How is CONCORD.BO’s Enterprise Value compared to its peers?

Concord Drugs Limited’s Enterprise Value is greater than Godavari Drugs Limited (550.25M), less than Makers Laboratories Limited (782.62M), greater than Vista Pharmaceuticals Limited (534.89M), less than Sunil Healthcare Limited (1.31B), greater than Vasundhara Rasayans Limited (619.75M), greater than Biofil Chemicals and Pharmaceuticals Limited (571.37M), greater than Rajnish Wellness Limited (507.39M), greater than Aspira Pathlab & Diagnostics Limited (696.63M), greater than Vivo Bio Tech Limited (493.88M), greater than Choksi Imaging Limited (715.49M),

Build a custom stock screener for Concord Drugs Limited (CONCORD.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Concord Drugs Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Concord Drugs Limited (CONCORD.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Concord Drugs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.